Cyclerion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Cyclerion Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Cyclerion Therapeutics Inc
Rating: 1.20566675
Author: Trendlyne DVM scores

about

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...

1.24 -0.14 (-10.14%)

80.16% Fall from 52W High

189.0K

XNAS Volume

XNAS 03 Feb, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

29.2 / 100

Technically Bearish

19.1 / 100

1Yr Price target upside is 545%

1 analysts

Cyclerion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cyclerion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...

80.16% Fall from 52W High

SWOT Analysis

Cyclerion Therapeutics Inc Live Price Chart